Literature DB >> 11892091

The mechanisms of aspirin-intolerant asthma and its management.

Maureen McGeehan1, Robert K Bush.   

Abstract

Aspirin is one of the most widely used medications in the world. Adverse effects related to aspirin use were described almost concurrently with its first use. The most common side effects are gastrointestinal and renal, but adverse respiratory effects are not uncommon, and approximately 10% of adult asthmatics are aspirin intolerant. Many of these patients present with the so-called aspirin triad of aspirin sensitivity, chronic rhinosinusitis with associated nasal polyposis, and severe asthma. This paper provides a review of recent investigations into the pathogenesis of this process, which have furthered our understanding of the mechanisms and management of aspirin-induced asthma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11892091     DOI: 10.1007/s11882-002-0006-1

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  56 in total

1.  Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma.

Authors:  A S Cowburn; K Sladek; J Soja; L Adamek; E Nizankowska; A Szczeklik; B K Lam; J F Penrose; F K Austen; S T Holgate; A P Sampson
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

Review 2.  The cyclooxygenase theory of aspirin-induced asthma.

Authors:  A Szczeklik
Journal:  Eur Respir J       Date:  1990-05       Impact factor: 16.671

3.  Intolerance to aspirin. Clinical studies and consideration of its pathogenesis.

Authors:  M Samter; R F Beers
Journal:  Ann Intern Med       Date:  1968-05       Impact factor: 25.391

4.  Aspirin intolerance and asthmal induction of a tolerance and long-term monitoring.

Authors:  P J Dor; D Vervloet; G Baldocchi; J Charpin
Journal:  Clin Allergy       Date:  1985-01

5.  Diagnosis, prevention, and treatment of adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs.

Authors:  D D Stevenson
Journal:  J Allergy Clin Immunol       Date:  1984-10       Impact factor: 10.793

6.  The potent and selective sulfidopeptide leukotriene antagonist, SK&F 104353, inhibits aspirin-induced asthma.

Authors:  P E Christie; C M Smith; T H Lee
Journal:  Am Rev Respir Dis       Date:  1991-10

7.  Aspirin-sensitive rhinosinusitis/asthma: spectrum of adverse reactions to aspirin.

Authors:  W W Pleskow; D D Stevenson; D A Mathison; R A Simon; M Schatz; R S Zeiger
Journal:  J Allergy Clin Immunol       Date:  1983-06       Impact factor: 10.793

8.  Aspirin desensitization in aspirin-sensitive asthma: failure to maintain a desensitized state during prolonged therapy.

Authors:  R E Dankner; H J Wedner
Journal:  Am Rev Respir Dis       Date:  1983-11

Review 9.  Aspirin and allergic diseases: a review.

Authors:  G A Settipane
Journal:  Am J Med       Date:  1983-06-14       Impact factor: 4.965

10.  Association of aspirin-sensitive asthma with HLA-DQw2.

Authors:  M F Mullarkey; P S Thomas; J A Hansen; D R Webb; B Nisperos
Journal:  Am Rev Respir Dis       Date:  1986-02
View more
  1 in total

Review 1.  A benefit-risk assessment of agents used in the secondary prevention of stroke.

Authors:  Ronald S MacWalter; Colin P Shirley
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.